Abstract
Although a variety of degenerative diseases are now known to be caused by two mutations in mitochondrial genes, the pathophysiology of these diseases remains poorly understood. As a consequence, relatively little progress has been made in developing new therapies for mitochondrial diseases. What has been needed are animal models for these diseases that are amenable to detailed biochemical, physiological, and molecular analysis, and on which promising therapies can be tested. In the past 5 yr, this deficiency has begun to be addressed by the construction of a number of mouse models of mitochondrial
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Wallace, D. C., Brown, M. D., and Lott, M. T. (1996) Mitochondrial genetics, in Emery and Rimoin’s Principles and Practice of Medical Genetics (Rimoin, D. L., et al., eds.), Churchill Livingstone, London, pp. 277–332.
Wallace, D. C. (1997) Mitochondrial DNA mutations and bioenergetic defects in aging and degenerative diseases, in The Molecular and Genetic Basis of Neurological Disease (Rosenberg, R. N., et al., eds.), Butterworth-Heinemann, Boston, pp. 237–269.
Shoffner, J. M. and Wallace, D. C. (1995) Oxidative phosphorylation diseases, in The Metabolic and Molecular Basis of Inherited Disease (Scriver, C. R., et al., eds.), McGraw-Hill, New York, pp. 1535–1609.
Green, D. R. and Reed, J. C. (1998) Mitochondria and apoptosis. Science 281(5381), 1309–1312.
Liu, X., et al. (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86(1), 147–157.
Brustovetsky, N. and Klingenberg, M. (1996) Mitochondrial ADP/ATP carrier can be reversibly converted into a large channel by Ca2+. Biochemistry 35(26), 8483–8488.
Marzo, I., et al. (1998) Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 281(5385), 2027–2031.
Wallace, D. C. (1999) Mitochondrial diseases in man and mouse. Science 283(5407), 1482–1488.
Wallace, D. C. (1992) Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 256, 628–632.
Wallace, D. C. (1992) Diseases of the mitochondrial DNA. Ann. Rev. Biochem. 61, 1175–1212.
Stepien, G., et al. (1992) Differential expression of adenine nucleotide translocator isoforms in mammalian tissues and during muscle cell differentiation. J. Biol. Chem. 267(21), 14,592–14,597.
Neckelmann, N., et al. (1987) cDNA sequence of a human skelet al muscle ADP/ATP translocator: lack of a leader peptide, divergence from a fibroblast translocator cDNA, and coevolution with mitochondrial DNA genes. Proc. Natl. Acad. Sci. USA 84(21), 7580–7584.
Houldsworth, J. and Attardi, G. (1988) Twodistinct genes for ADP/ATPtranslocase are expressed at the mRNA level in adult human liver. Proc. Natl. Acad. Sci. USA 85(2), 377–381.
Giraud, S., et al. (1998) Expression of human ANT2 gene in highly proliferative cells: GRBOX, a new transcriptional element, is involved in the regulation of glycolytic ATP import into mitochondria. J. Mol. Biol. 281(3), 409–418.
Cozens, A. L., Runswick, M. J., and Walker, J. E. (1989) DNA sequences of two expressed nuclear genes for human mitochondrial ADP/ATP translocase. J. Mol. Biol. 206(2), 261–280.
Li, K., et al. (1989) A human muscle adenine nucleotide translocator gene has four exons, is located on chromosome 4, and is differentially expressed. J. Biol. Chem. 264(24), 13,998–14,004.
Wijmenga, C., et al. (1993) The human skelet al muscle adenine nucleotide translocator gene maps to chromosome 4q35 in the region of the facioscapulohumeral muscular dystrophy locus. Hum. Genet. 92(2), 198–203.
Wijmenga, C., et al. (1992) Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nature Genet. 2(1), 26–30.
Haraguchi, Y., et al. (1993) Genetic mapping of human heart-skelet al muscle adenine nucleotide translocator and its relationship to the facioscapulohumeral muscular dystrophy locus. Genomics 16(2), 479–485.
Battini, R., et al. (1987) Molecular cloning of a cDNA for a human ADP/ATP carrier which is growth-regulated. J. Biol. Chem. 262(9), 4355–4359.
Chen, S. T., et al. (1990) A human ADP/ATP translocase gene has seven pseudogenes and localizes to chromosome X. Somatic Cell Mol. Genet. 16(2), 143–149.
Ku, D. H., et al. (1990) The human fibroblast adenine nucleotide translocator gene. Molecular cloning and sequence. J. Biol. Chem. 265(27), 16,060–16,063.
Schiebel, K., et al. (1994) Localization of the adenine nucleotide translocase gene ANT2 to chromosome Xq24-q25 with tight linkage to DXS425. Genomics 24(3), 605–606.
Schiebel, K., et al. (1993) A human pseudoautosomal gene, ADP/ATP translocase, escapes X-inactivation whereas a homologue on Xq is subject to X-inactivation. Nature Genet. 3(1), 82–87.
Slim, R., et al. (1993) A human pseudoautosomal gene encodes the ANT3 ADP/ATP translocase and escapes X-inactivation. Genomics 16(1), 26–33.
Levy, S. E., et al. (2000) Expression and sequence analysis of the mouse adenine nucleotide translocase 1 and 2 genes. Gene 254, 57–66.
Graham, B., et al. (1997) A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/skelet al muscle isoform of the adenine nucleotide translocator. Nature Genet. 16(3), 226–234.
Mills, K. A., Ellison, J. W., and Mathews, K. D. (1996) The Ant1 gene maps near Klk3 on proximal mouse chromosome 8. Mammal. Genome 7(9), 707.
Ellison, J. W., et al. (1996) Rapid evolution of human pseudoautosomal genes and their mouse homologs. Mammal. Genome 7(1), 25–30.
Cassard, A. M., et al. (1990) Human uncoupling protein gene: structure, comparison with rat gene, and assignment to the long arm of chromosome 4. J. Cell. Biochem. 43(3), 255–264.
Kozak, L. P., et al. (1988) The mitochondrial uncoupling protein gene. Correlation of exon structure to transmembrane domains. J. Biol. Chem. 263(25), 12,274–12,277.
Jacobsson, A., et al. (1985) Mitochondrial uncoupling protein from mouse brown fat. Molecular cloning, genetic mapping, and mRNA expression. J. Biol. Chem. 260(30), 16,250–16,254.
Fleury, C., et al. (1997) Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia [see comments]. Nature Genet. 15(3), 269–272.
Gong, D. W., et al. (1997) Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, beta3-adrenergic agonists, and leptin. J. Biol. Chem. 272(39), 24,129–24,132.
Solanes, G., et al. (1997) The human uncoupling protein-3 gene. Genomic structure, chromosomal localization, and genetic basis for short and long form transcripts. J. Biol. Chem. 272(41), 25,433–25,436.
Vidal-Puig, A., et al. (1997) UCP3: an uncoupling protein homologue expressed preferentially and abundantly in skelet al muscle and brown adipose tissue. Biochem. Biophys. Res. Commun. 235(1), 79–82.
Boss, O., et al. (1997) Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression. FEBS Lett. 408(1), 39–42.
Ksenzenko, M., et al. (1983) Effect of electron transfer inhibitors on superoxide generation in the cytochrome bc1 site of the mitochondrial respiratory chain. FEBS Lett. 155(1), 19–24.
Turrens, J. F., Alexandre, A., and Lehninger, A. L. (1985) Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria. Arch. Biochem. Biophys. 237(2), 408–414.
Boveris, A. and Turrens, J. F. (1980) Production of superoxide anion by the NADH-dehydrogenase of mamalian mitochondria, in Chemical and Biochemical Aspects of Superoxide and Superoxide Dismutase. Developments in Biochemistry (Bannister, J. V. and Hill, H. A. O., eds.), Elsevier-North Holland, New York, pp. 84–91.
Turrens, J. F. and Boveris, A. (1980) Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem. J. 191(2), 421–427.
Bandy, B. and Davison, A. J. (1990) Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging? Free Radical Biol. Med. 8(6), 523–539.
Goldhaber, J. I. and Weiss, J. N. (1992) Oxygen free radicals and cardiac reperfusion abnormalities. Hypertension 20(1), 118–127.
Yan, L. J., Levine, R. L., and Sohal, R. S. (1997) Oxidative damage during aging targets mitochondrial aconitase [published erratum appears in Proc. Natl. Acad. Sci. US 1998 Feb 17;95(4):1968]. Proc. Natl. Acad. Sci. USA 94(21), 11,168–11,172.
Rotig, A.,et al. (1997) Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nature Genet. 17(2), 215–217.
Boveris, A., Oshino, N., and Chance, B. (1972) The cellular production of hydrogen peroxide. Biochem. J. 128(3), 617–630.
Boveris, A. (1984) Determination of the production of superoxide radicals and hydrogen peroxide in mitochondria. Methods Enzymol. 105, 429–435.
Cadenas, E. and Boveris, A. (1980) Enhancement of hydrogen peroxide formation by protophores and ionophores in antimycin-supplemented mitochondria. Biochem. J.. 188(1), 31–37.
Chance, B., Sies, H., and Boveris, A. (1979) Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59(3), 527–605.
Loschen, G., et al. (1974) Superoxide radicals as precursors of mitochondrial hydrogen peroxide. FEBS Lett. 42(1), 68–72.
Petit, P. X., et al. (1996) Mitochondria and programmed cell death: back to the future. FEBS Lett. 396(1), 7–13.
Zoratti, M. and Szabo, I. (1995) The mitochondrial permeability transition. Biochim. Biophys. Acta 1241(2), 139–176.
Mancini, M., et al. (1998) The caspase-3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling. J. Cell Biol. 140(6), 1485–1495.
Earnshaw, W. C. (1999) Apoptosis. A cellular poison cupboard [news]. Nature 397(6718), 387–389.
Susin, S. A., et al. (1999) Molecular characterization of mitochondrial apoptosisinducing factor. Nature 397(6718), 441–446.
Susin, S. A., et al. (1999) Mitochondrial release of caspase-2 and-9 during the apoptotic process. J. Exp. Med. 189(2), 381–394.
Woo, M., et al. (1998) Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 12(6), 806–819.
Li, K., et al. (2000) Cytochrome c deficiency causes embryonic lethality and attenuates stress-induced apoptosis. Cell 101(4), 389–399.
Szabo, C. (1997) Role of poly(ADP-ribose) synthetase activation in the suppression of cellular energetics in response to nitric oxide and peroxynitrite. Biochem. Soc. Trans. 25(3), 919–924.
Snyder, S. H., Jaffrey, S. R., and Zakhary, R. (1998) Nitric oxide and carbon monoxide: parallel roles as neural messengers. Brain Res. Rev. 26(2-3), 167–175.
Eliasson, M. J.,et al. (1997) Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nature Med. 3(10), 1089–1095.
Takahashi, K., et al. (1999) Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemia. Brain Res. 829(1-2), 46–54.
Pieper, A. A., et al. (1999) Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. USA 96(6), 3059–3064.
Schuler, M., et al. (2000) p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. J. Biol. Chem. 275(10), 7337–7342.
Lin, S. J., Defossez, P. A., and Guarente, L. (2000) Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae [see comments]. Science 289(5487), 2126–2128.
Suh, Y. A., et al. (1999) Cell transformation by the superoxide-generating oxidase Mox1. Nature 401(6748), 79–82.
Arnold, R. S., Shi, J., Murad, E., Whalen, A. M., et al. (2001) Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1. Proc. Natl. Acad. Sci. USA 98, 5550–5555.
Chang, D.D. and Clayton, D. A. (1987) A mammalian mitochondrial RNA processing activity contains nucleus-encoded RNA. Science 235(4793), 1178–1184.
Chang, D. D. and Clayton, D. A. (1987) A novel endoribonuclease cleaves at a priming site of mouse mitochondrial DNA replication. EMBO J. 6(2), 409–417.
Chang, D. D. and Clayton, D. A. (1989) Mouse RNAase MRP RNA is encoded by a nuclear gene and contains a decamer sequence complementary to a conserved region of mitochondrial RNA substrate. Cell 56(1), 131–139.
Clayton, D. A. (1994) A nuclear function for RNase MRP. Proc. Natl. Acad. Sci. USA 91(11), 4615–4617.
Fisher, R. P., Topper, J. N., and Clayton, D. A. (1987) Promoter selection in human mitochondria involves binding of a transcription factor to orientation-independent upstream regulatory elements. Cell 50(2), 247–258.
Dairaghi, D. J., Shadel, G. S., and Clayton, D. A. (1995) Addition of a 29 residue carboxyl-terminal tail converts a simple HMG box-containing protein into a transcriptional activator. J. Mol. Biol. 249(1), 11–28.
Ghivizzani, S. C., et al. (1994) In organello footprint analysis of human mitochondrial DNA: human mitochondrial transcription factor A interactions at the origin of replication. Mol. Cell. Biol. 14(12), 7717–7730.
Ghivizzani, S. C., Madsen, C. S., and Hauswirth, W. W. (1993) In organello foot-printing. Analysis of protein binding at regulatory regions in bovine mitochondrial DNA. J. Biol. Chem. 268(12), 8675–8682.
Ikeda, S., Sumiyoshi, H., and Oda, T. (1994) DNA binding properties of recombinant human mitochondrial transcription factor 1. Cell. Mol. Biol. 40(4), 489–493.
Bunn, C. L., Wallace, D. C., and Eisenstadt, J. M. (1974) Cytoplasmic inheritance of chlormaphenicol resistance in mouse tissue culture cells. Proc. Natl. Acad. Sci. USA 71(5), 1681–1685.
Wallace, D. C., Bunn, C. L., and Eisenstadt, J. M. (1975) Cytoplasmic transfer of chloramphenicol resistance in human tissue culture cells. J. Cell Biol. 67(1), 174–188.
Wallace, D. C. (1982) Cytoplasmic inheritance of chloramphenicol resistance in mammalian cells, in Techniques in Somatic Cell Genetics (Shay, J. W., ed.), Plenum, New York, pp. 159–187.
Ziegler, M. L. and Davidson, R. L. (1981) Elimination of mitochondrial elements and improved viability in hybrid cells. Somatic Cell Genet. 7(1), 73–88.
Trounce, I. and Wallace, D. C. (1996) Production of transmitochondrial mouse cell lines by cybrid rescue of rhodamine-6G pre-treated L-cells. Somatic Cell Mol. Genet. 22(1), 81–85.
King, M. P. and Attardi, G. (1989) Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 246(4929), 500–503.
Trounce, I. A., et al. (1996) Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol. 264, 484–509.
Blanc, H., et al. (1981) Mitochondrial DNA of chloramphenicol-resistant mouse cells contains a single nucleotide change in the region encoding the 3 end of the large ribosomal RNA. Proc. Natl. Acad. Sci. USA 78(6), 3789–3793.
Blanc, H., Adams, C.W., and Wallace, D. C. (1981) Different nucleotide changes in the large rRNA gene of the mitochondrial DNA confer chloramphenicol resistance on two human cell lines. Nucleic Acids Res. 9(21), 5785–5795.
Wallace, D. C., et al. (2001) Mitochondria and neuro-ophthalmological diseases, in The Metabolic and Molecular Basis of Inherited Disease (Scriver, C. R., et al., eds.), McGraw-Hill, New York, pp. 2425–2512.
Wallace, D. C., et al. (1988) Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease. Cell 55(4), 601–610.
Shoffner, J. M., et al. (1990) Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNALys mutation. Cell 61(6), 931–937.
Goto, Y., Nonaka, I., and Horai, S. (1990) A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies [see comments]. Nature 348(6302), 651–653.
van den Ouweland, J. M., et al. (1994) Maternally inherited diabetes and deafness is a distinct subtype of diabetes and associates with a single point mutation in the mitochondrial tRNALeu(UUR) gene. Diabetes 43(6), 746–751.
van den Ouweland, J. M., et al. (1992) Mutations in mitochondrial tRNA genes: non-linkage with syndromes of Wolfram and chronic progressive external ophthalmoplegia. Nucleic Acids Res. 20(4), 679–682.
van den Ouweland, J. M., et al. (1992) Mutation in mitochondrial tRNALeu(UUR)gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nature Gen. 1, 368–371.
Shoffner, J. M., et al. (1995) Mitochondrial encephalomyopathy associated with a single nucleotide pair deletion in the mitochondrial tRNALeu(UUR) gene. Neurology 45(2), 286–292.
Hutchin, T., et al. (1993) A molecular basis for human hypersensitivity to aminoglycoside antibiotics. Nucleic Acids Res. 21(18), 4174–4179.
Prezant, T. R., et al. (1993) Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nature Genet. 4(3), 289–294.
Ballinger, S. W., et al. (1992) Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nature Genet. 1, 11–15.
Ballinger, S. W., et al. (1994) Mitochondrial diabetes revisited [letter]. Nature Genet. 7(4), 458–459.
Holt, I. J., Harding, A. E., and Morgan-Hughes, J. A. (1988) Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 331(6158), 717–719.
Shoubridge, E. A., Karpati, G., and Hastings, K. E. M. (1990) Deletion mutants are functionally dominant over wild-type mitochondrial genomes in skelet al muscle fiber segments in mitochondrial disease. Cell 62(1), 43–49.
Mitani, I., et al. (1998) Detection of mitochondrial DNA nucleotide 11778 point mutation of Leber hereditary optic neuropathy from archival stained histopathological preparations. Acta Ophthalmol. Scand. 76(1), 14–19.
Pearson, H. A., et al. (1979) A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic function. J. Pediatr. 95(6), 976.
Kapsa, R., et al. (1994) A novel mtDNA deletion in an infant with Pearson syndrome. J. Inherited Metab. Dis. 17(5), 521–526.
Cormier, V., et al. (1991) Pearson’s syndrome. Pancytopenia with exocrine pancreatic insufficiency: new mitochondrial disease in the first year of childhood. Arch. Fr. Pediatr. 48(3), 171–178.
McShane, M. A., et al. (1991) Pearson syndrome and mitochondrial encephalomyopathy in patient with a deletion of mtDNA. Am. J. Hum. Genet. 48(1), 39–42.
Poulton, J., et al. (1995) Mitochondrial DNA, diabetes and pancreatic pathology in Kearns-Sayre syndrome. Diabetologia 38(7), 868–871.
Rotig, A., et al. (1995) Spectrum of mitochondrial DNA rearrangements in the Pearson marrow-pancreas syndrome. Hum. Mol. Genet. 4(8), 1327–1330.
Heddi, A., et al. (1999) Coordinate induction of energy gene expression in tissues of mitochondrial disease patients. J. Biol. Chem. 274(33), 22,968–22,976.
Heddi, A., et al. (1993) Mitochondrial DNA expression in mitochondrial myopathies and coordinated expression of nuclear genes involved in ATP production. J. Biol. Chem. 268(16), 12,156–12,163.
Heddi, A., et al. (1994) Steady state levels of mitochondrial and nuclear oxidative phosphorylation transcripts in Kearns-Sayre syndrome. Biochim. Biophys. Acta 1226(2), 206–212.
Stachowiak, O., et al. (1998) Mitochondrial creatine kinase is a prime target of peroxynitrite-induced modification and inactivation. J. Biol. Chem. 273(27), 16,694–16,699.
Suomalainen, A. and Kaukonen, J. (2001) Diseases caused by nuclear genes affecting mtDNA stability. Am. J. Med. Genet. 106, 53–61.
Orth M. and Schapira, A. H. (2001) Mitochondria and degenerative disorders. Am. J. Med. Genet. 106, 27–36.
Shoubridge, E. A. (2001) Cytochrome c oxidase deficiency. Am. J. Med. Genet. 106, 46–52.
Triepels, R. H., Van Den Heuvel, L. P., Trijbels, J. M., Smeitink, J. A. (2001) Respiratory chain complex I deficiency. Am. J. Med. Genet. 106, 37–45.
Ridanpaa, M., et al. (2001) Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia. Cell p. 195–203.
Tritschler, H.-J., et al. (1992) Mitochondrial myopathy of childhood associated with depletion of mitochondrial DNA. Neurology 42(1), 209–217.
Mazziotta, M. R., et al. (1992) Fatal infantile liver failure associated with mitochondrial DNA depletion. J. Pediatr. 121(6), 896–901.
Moraes, C. T., et al. (1991) MtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am. J. Hum. Genet. 48(3), 492–501.
Dahl, H. H. (1998) Getting to the nucleus of mitochondrial disorders: identification of respiratory chain-enzyme genes causing Leigh syndrome [editorial; comment]. Am. J. Hum. Genet. 63(6), 1594–1597.
Zhu, Z., et al. (1998) SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nature Genet. 20(4), 337–343.
Tiranti, V., et al. (1998) Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am. J. Hum. Genet. 63(6), 1609–1621.
Valnot, I., et al. (2000) Mutations in SC01 gene causes mitochondrial cytochrome c oxidase deficiency presenting as neonatal-onset hepatic failure and encephalopathy. Am. J. Hum. Genet. 67(4 Suppl. 2), A20 (abstract).
Papadopoulou, L. C., et al. (1999) Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nature Gen. 23(3), 333–337.
Dickinson, E. K., et al. (2000) A human SCO2 mutation helps define the role of Sco1p in the cytochrome oxidase assembly pathway. J. Biol. Chem. 275(35), 26,780–26,785.
Jin, H., et al. (1996) A novel X-linked gene, DDP, shows mutations in families with deafness (DFN-1), dystonia, mental deficiency and blindness. Nature Genet. 14(2), 177–180.
Wallace, D. C. and Murdock, D. G. (1999) Mitochondria and dystonia: the movement disorder connection? Proc. Natl. Acad. Sci. USA 96(5), 1817–1819.
Koehler, C. M., et al. (1999) Human deafness dystonia syndrome is a mitochon-drial disease. Proc. Natl. Acad. Sci. USA 96(5), 2141–2146.
Wilson, R. B. and Roof, D. M. (1997) Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue. Nature Genet. 16(4), 352–357.
Koutnikova, H., et al. (1997) Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin. Nature Genet. 16(4), 345–351.
Zeviani, M., et al. (1989) An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature 339(6222), 309–311.
Zeviani, M., et al. (1990) Nucleus-driven multiple large-scale deletions of the human mitochondrial genome: a new autosomal dominant disease. Am. J. Hum. Genet. 47, 904–914.
Cormier, V., et al. (1991) Autosomal dominant deletions of the mitochondrial genome in a case of progressive encephalomyopathy. Am. J. Hum. Genet. 48(4), 643–648.
Moraes, C. T., et al. (1993) Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. Neuromuscul. Dis. 3(1), 43–50.
Checcarelli, N., et al. (1994) Multiple deletions of mitochondrial DNA in sporadic and atypical cases of encephalomyopathy. J. Neurol. Sci. 123(1-2), 74–79.
Suomalainen, A., et al. (1992) Multiple deletions of mitochondrial DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia. J. Clin. Invest. 90, 61–66.
Suomalainen, A., et al. (1995) An autosomal locus predisposing to deletions of mitochondrial DNA. Nature Genet. 9(2), 146–151.
Zeviani, M., et al. (1995) Searching for genes affecting the structural integrity of the mitochondrial genome. Biochim. Biophys. Acta 1271(1), 153–158.
Kaukonen, J., et al. (2000) Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 289(5480), 782–785.
Nishino, I., Spinazzola, A., and Hirano, M. (1999) Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283(5402), 689–692.
Boffoli, D., et al. (1994) Decline with age of the respiratory chain activity in human skelet al muscle. Biochim. Biophys. Acta 1226(1), 73–82.
Cooper, J. M., Mann, V. M., and Schapira, A. H. V. (1992) Analyses of mitochondrial respiratory chain function and mitochondrial DNA deletion in human skelet al muscle: effect of ageing. J. Neurol. Sci. 113(1), 91–98.
Trounce, I., Byrne, E., and Marzuki, S. (1989) Decline in skelet al muscle mitochondrial respiratory chain function: possible factor in ageing. Lancet 1, 637–639.
Yen, T. C., et al. (1989) Liver mitochondrial respiratory functions decline with age. Biochem. Biophys. Res. Commun. 165, 944–1003.
Bowling, A. C.,et al. (1993) Age-dependent impairment of mitochondrial function in primate brain. J. Neurochem. 60(5), 1964–1967.
Cortopassi, G. A. and Arnheim, N. (1990) Detection of a specific mitochondrial DNA deletion in tissues of older humans. Nucleic Acids Res. 18(23), 6927–6933.
Cortopassi, G. A., et al. (1992) A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues. Proc. Natl. Acad. Sci. USA 89(16), 7370–7374.
Cortopassi, G. A., Pasinetti, G., and Arnheim, N. (1992) Mosaicism for levels of a somatic mutation of mitochondrial DNA in different brain regions and its implications for neurological disease, in Progress in Parkinson’s Disease Research II (Hatefi, F. and Weiner, W. J., eds.), Futura, Mt. Kisco, NY.
Linnane, A. W., et al. (1990) Mitochondrial gene mutation: the aging process and degenerative diseases. Biochem. Int. 22(6), 1067–1076.
Zhang, C., et al. (1992) Multiple mitochondrial DNA deletions in an elderly human individual. FEBS Lett. 297, 4–8.
Corral-Debrinski, M., et al. (1992) Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nature Genet. 2(4), 324–329.
Soong, N. W., et al. (1992) Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain. Nature Genet. 2, 318–323.
Corral-Debrinski, M., et al. (1991) Hypoxemia is associated with mitochondrial DNA damage and gene induction. JAMA 266(13), 1812–1816.
Corral-Debrinski, M., et al. (1992) Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. Mutat. Res. 275(3-6), 169–180.
Simonetti, S., et al. (1992) Accumulation of deletions in human mitochondrial DNA during normal aging: analysis by quantitative PCR. Biochim. Biophys. Acta 1180(2), 113–122.
Jazin, E. E., et al. (1996) Human brain contains high levels of heteroplasmy in the noncoding regions of mitochondrial DNA. Proc. Natl. Acad. Sci. USA 93(22), 12,382–12,387.
Michikawa, Y., et al. (1999) Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science 286(5440), 774–779.
Murdock, D. G., Christacos, N. C., and Wallace, D. C. (2000) The age-related accumulation of a mitochondrial DNA control region mutation in muscle, but not brain, detected by a sensitive PNA-directed PCR clamping based method. Nucleic Acids Res. 28(21), 4350–4355.
Trounce, I., et al. (2000) Cloning of neuronal mtDNA variants in cultured cells by synaptosome fusion with mtDNA-less cells. Nucleic Acids Res. 28(10), 2164–2170.
Richter, C., Park, J. W. and Ames, B. N. (1988) Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc. Natl. Acad. Sci. USA 85(17), 6465–6467.
Ames, B. N., Shigenaga, M. K. and Hagen, T. M. (1993) Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA 90(17), 7915–7922.
Hayakawa, M., et al. (1993) Age-associated damage in mitochondrial DNA in human hearts. Mol. Cell. Biochem. 119(1-2), 95–103.
Mecocci, P., et al. (1993) Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann. Neurol. 34(4), 609–616.
Muller-Hocker, J. (1990) Cytochrome c oxidase deficient fibres in the limb muscle and diaphragm of man without muscular disease: an age-related alteration. J. Neurol. Sci. 100, 14–21.
Muller-Hocker, J., et al. (1992) Progressive loss of cytochrome c oxidase in the human extraocular muscles in ageing-a cytochemical-immunohistochmeical study. Mutat. Res. 275, 115–124.
Muller-Hocker, J., et al. (1993) Different in situ hybridization patterns of mitochondrial DNA in cytochrome c oxidase-deficient extraocular muscle fibres in the elderly. Virchows Arch A, Pathol. Anat. Histopathol. 422, 7–15.
Khrapko, K., et al. (1999) Cell-by-cell scanning of whole mitochondrial genomes in aged human heart reveals a significant fraction of myocytes with clonally expanded deletions. Nucleic Acids Res. 27(11), 2434–2441.
Melov, S., et al. (1997) Multi-organ characterization of mitochondrial genomic rearrangements in ad libitum and caloric restricted mice show striking somatic mitochondrial DNA rearrangements with age. Nucleic Acids Res. 25(5), 974–982.
Lee, C. K., et al. (1999) Gene expression profile of aging and its retardation by caloric restriction. Science 285(5432), 1390–1393.
Lee, C. K., Weindruch, R., and Prolla, T. A. (2000) Gene-expression profile of the ageing brain in mice. Nature Genet. 25(3), 294–297.
Masoro, E. J. (1993) Dietary restriction and aging. J. Am. Geriatr. Soc. 41(9), 994–999.
Masoro, E. J., et al. (1992) Dietary restriction alters characteristics of glucose fuel use (published erratum appears in J. Gerontol. 1993 Mar;48(2):B73). J. Gerontol. 47(6), B202–B208.
McCarter, R. J. and Palmer, J. (1992) Energy metabolism and aging: a lifelong study of Fischer 344 rats. Am. J. Physiol. 263(3 Pt. 1), E448–E452.
Sohal, R. S., et al. (1994) Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse. Mech. Ageing Dev. 74(1-2), 121–133.
Harrison, D. E. and Archer, J. R. (1987) Genetic differences in effects of food restriction on aging in mice. J. Nutr. 117(2), 376–382.
Yan, L. J. and Sohal, R. S. (1998) Mitochondrial adenine nucleotide translocase is modified oxidatively during aging. Proc. Natl. Acad. Sci. USA 95(22), 12,896–12,901.
Sohal, R. S. and Dubey, A. (1994) Mitochondrial oxidative damage, hydrogen peroxide release, and aging. Free Radical Biol. Med. 16(5), 621–626.
Dorner G. and Mohnike, A. (1976) Further evidence for a predominantly maternal transmission of maturity-onset type diabetes. Endokrinologie 68(1), 121–124.
Dorner, G., Mohnike, A., and Steindel, E. (1975) On possible genetic and epigenetic modes of diabetes transmission. Endokrinologie 66(2), 225–227.
Dorner, G., Plagemann, A., and Reinagel, H. (1987) Familial diabetes aggregation in type I diabetics: gestational diabetes an apparent risk factor for increased diabetes susceptibility in the offspring. Exp. Clin. Endocrinol. 89(1), 84–90.
Freinkel, N., et al. (1986) Gestational diabetes mellitus: a syndrome with phenotypic and genotypic heterogeneity. Horm. Metab. Res. 18(7), 427–430.
Pimentel, E. (1979) Some aspects of the genetics and etiology of spontaneous diabetes mellitus. Acta Diabetol. Latina 16(3), 193–201.
Alcolado, J. C. and Thomas, A. W. (1995) Maternally inherited diabetes mellitus: the role of mitochondrial DNA defects. Diabetic Med. 12(2), 102–108.
Gerbitz, K. D., et al. (1995) Mitochondrial diabetes mellitus: a review. Biochim. Biophys. Acta 1271(1), 253–260.
Gerbitz, K. D., Gempel, K., and Brdiczka, D. (1996) Mitochondria and diabetes. Genetic, biochemical, and clinical implications of the cellular energy circuit. Diabetes 45(2), 113–126.
Alcolado, J. C., et al. (1994) Insulin resistance and impaired glucose tolerance [letter; comment]. Lancet 344(8932), 1293–1294.
Kadowaki, T., et al. (1995) A subtype of diabetes mellitus associated with a mutation in the mitochondrial gene. Muscle Nerve 3(41), S137–S141.
Suzuki, S., et al. (1994) Pancreatic beta-cell secretory defect associated with mitochondrial point mutation of the tRNALeu(UUR) gene: a study in seven families with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS). Diabetologia 37(8), 818–825.
Kanamori, A., et al. (1994) Insulin resistance in mitochondrial gene mutation. Diabetes Care 17(7), 778–779.
Kanamori, A., et al. (1995) Response to Walker et al. (Insulin sensitivity and mitochondrial gene mutation). Diabetes Care 18(2), 274–275.
Odawara, M., et al. (1995) Mitochondrial gene mutation as a cause of insulin resistance. Diabetes Care 18(2), 275.
Koster, J. C., et al. (2000) Targeted overactivity of beta cell K(ATP) channels induces profound neonatal diabetes. Cell 100(6), 645–654.
German, M. S. (1993) Glucose sensing in pancreatic islet beta cells: the key role of glucokinase and the glycolytic intermediates. Proc. Natl. Acad. Sci. USA 90(5), 1781–1785.
Gidh-Jain, M., et al. (1993) Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships. Proc. Natl. Acad. Sci. USA 90(5), 1932–1936.
Stoffel, M., et al. (1992) Human glucokinase gene: isolation, characterization, and identification of two missense mutations linked to early-onset non-insulin-dependent (type 2) diabetes mellitus [published erratum appears in Proc. Natl. Acad. Sci. USA 89(21): 10,562]. Proc. Natl. Acad. Sci. USA 89(16), 7698–7702.
Stoffel, M., et al. (1992) Missense glucokinase mutation in maturity-onset diabetes of the young and mutation screening in late-onset diabetes. Nature Genet. 2(2), 153–156.
Stoffel, M., et al. (1993) Identification of glucokinase mutations in subjects with gestational diabetes mellitus. Diabetes 42(6), 937–940.
Gelb, B. D., et al. (1992) Targeting of hexokinase 1 to liver and hepatoma mitochondria. Proc. Natl. Acad. Sci. USA 89(1), 202–206.
Malaisse-Lagae, F. and Malaisse, W. J. (1988) Hexose metabolism in pancreatic islets: regulation of mitochondrial hexokinase binding. Biochem. Med. Metab. Biol. 39(1), 80–89.
Adams, V., et al. (1991) Porin interaction with hexokinase and glycerol kinase: metabolic microcompartmentation at the outer mitochondrial membrane. Biochem. Med. Metab. Biol. 45(3), 271–291.
McCabe, E. R. (1994) Microcompartmentation of energy metabolism at the outer mitochondrial membrane: role in diabetes mellitus and other diseases. J. Bioenerg. Biomembr. 26(3), 317–325.
Wallace, D. C. (1994) Mitochondrial DNA mutations in diseases of energy metabolism. J. Bioenerg. Biomembr. 26(3), 241–250.
Wollheim, C. B. (2000) Beta-cell mitochondria in the regulation of insulin secretion: a new culprit in type II diabetes. Diabetologia 43(3), 265–277.
Eto, K., et al. (1999) Role of NADH shuttle system in glucose-induced activation of mitochondrial metabolism and insulin secretion. Science 283(5404), 981–985.
Velho, G. and Froguel, R (1998) Genetic, metabolic and clinical characteristics of maturity onset diabetes of the young. Eur. J. Endocrinology 138(3), 233–239.
Altshuler, D., et al. (2000) The common PPARgammaPro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nature Genet. 26(1), 76–80.
Gebhart, S. S.,et al. (1996) Insulin resistance associated with maternally inherited diabetes and deafness. Metabolism 45(4), 526–531.
Nishikawa, T., et al. (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404(6779), 787–790.
Sligh, J. E., et al. (2000) Maternal germ-line transmission of mutant mtDNAs from embryonic stem cell-derived chimeric mice. Proc. Natl. Acad. Sci. USA 97(26), 14,461–14,466.
Inoue, K., et al. (2000) Generation of mice with mitochondrial dysfunction by introducing mouse mtDNA carrying a deletion into zygotes, Nature Genet. 26, 176–181.
Watanabe, T., Dewey, M. J., and Mintz, B. (1978) Teratocarcinoma cells as vehicles for introducing specific mutant mitochondrial genes into mice. Proc. Natl. Acad. Sci. USA 75(10), 5113–5117.
Levy, S. E., et al. (1999) Transfer of chloramphenicol-resistant mitochondrial DNA into the chimeric mouse. Transgen. Res. 8(2), 137–145.
Marchington, D. R., Barlow, D., and Poulton, J. (1999) Transmitochondrial mice carrying resistance to chloramphenicol on mitochondrial DNA: developing the first mouse model of mitochondrial DNA disease. Nature Med. 5(8), 957–960.
Ferris, S. D., Sage, R. D., and Wilson, A. C. (1982) Evidence from mtDNA sequences that common laboratory strains of inbred mice are descended from a single female. Nature 295(5845), 163–165.
Pinkert, C. A., et al. (1997) Mitochondria transfer into mouse ova by microinjection. Transgen. Res. 6(6), 379–383.
Irwin, M. H., Johnson, L. W., and Pinkert, C. A. (1999) Isolation and microinjection of somatic cell-derived mitochondria and germline heteroplasmy in transmitochondrial mice. Transgen. Res. 8(2), 119–123.
Jenuth, J. P., et al. (1996) Random genetic drift in the female germline explains the rapid segregation of mammalian mitochondrial DNA [see comments]. Nature Genet. 14(2), 146–151.
Jenuth, J. P., Peterson, A. C., and Shoubridge, E. A. (1997) Tissue-specific selection for different mtDNA genotypes in heteroplasmic mice. Nature Genet. 16(1), 93–95.
Meirelles, F. V. and Smith, L. C. (1998) Mitochondrial genotype segregation during preimplantation development in mouse heteroplasmic embryos. Genetics 148(2), 877–883.
Meirelles, F. V. and Smith, L. C. (1997) Mitochondrial genotype segregation in a mouse heteroplasmic lineage produced by embryonic karyoplast transplantation. Genetics 145(2), 445–451.
Larsson, N. G., et al. (1998) Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice [see comments]. Nature Genet. 18(3), 231–236.
Wang, J., et al. (1999) Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expres-sion. Nature Genet. 21(1), 133–137.
Silva, J. P., et al. (2000) Impaired insulin secretion and beta-cell loss in tissue-specific knockout mice with mitochondrial diabetes. Nature Genet. 26(3), 336–340.
Murdock, D., et al. (1999) Up-regulation of nuclear and mitochondrial genes in the skelet al muscle of mice lacking the heart/muscle isoform of the adenine nucleotide translocator. J. Biol. Chem. 274(20), 14,429–14,433.
Esposito, L. A., et al. (1999) Mitochondrial disease in mouse results in increased oxidative stress. Proc. Natl. Acad. Sci. USA 96(9), 4820–4825.
Ridley, R. G., et al. (1986) Complete nucleotide and derived amino acid sequence of cDNA encoding the mitochondrial uncoupling protein of rat brown adipose tissue: lack of a mitochondrial targeting presequence. Nucleic Acids Res. 14(10), 4025–4035.
Reichling, S., et al. (1987) Loss of brown adipose tissue uncoupling protein mRNA on deacclimation of cold-exposed rats. Biochem. Biophys. Res. Commun. 142(3), 696–701.
Nicholls, D. G. and Locke, R. M. (1984) Thermogenic mechanisms in brown fat. Physiol. Rev. 64(1), 1–64.
Thomas, S. A. and Palmiter, R. D. (1997) Thermoregulatory and metabolic phenotypes of mice lacking noradrenaline and adrenaline. Nature 387(6628), 94–97.
Enerback, S., et al. (1997) Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese. Nature 387(6628), 90–94.
Arsenijevic, D., et al. (2000) Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nature Genet. 26(4), 435–439.
Vidal-Puig, A. J., et al. (2000) Energy metabolism in uncoupling protein 3 gene knockout mice. J. Biol. Chem. 275(21), 16,258–16,266.
Zhang, C., et al. (2001) Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 105(6), 745–755.
Polonsky, K. S. and Semenkovich, C. F. (2001) The pancreatic beta cell heats up. UCP2 and insulin secretion in diabetes. Cell 105(6), 705–707.
Esposito, L. A., et al. (2000) Mitochondrial oxidative stress in mice lacking the glutathione peroxidase-1 gene. Free Radical Biol. Med. 28(5), 754–766.
Cortopassi, G. and Wang, E. (1995) Modelling the effects of age-related mtDNA mutation accumulation; complex I deficiency, superoxide and cell death. Biochim. Biophys. Acta 1271(1), 171–176.
Li, Y., et al. (1995) Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nature Genet. 11(4), 376–381.
Lebovitz, R. M., et al. (1996) Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc. Natl. Acad. Sci. USA 93(18), 9782–9787.
Melov, S., et al. (1998) A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase [see comments]. Nature Genet. 18(2), 159–163.
Reaume, A. G., et al. (1996) Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nature Genet. 13(1), 43–47.
Carlsson, L. M., et al. (1995) Mice lacking extracellular superoxide dismutase are more sensitive to hyperoxia. Proc. Natl. Acad. Sci. USA 92(14), 6264–6268.
Melov, S., et al. (1999) Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc. Natl. Acad. Sci. USA 96(3), 846–851.
Kokoszka, J. E., et al. (2001) Increased mitochondrial oxidative stress in the Sod2 (+/-) mouse results in the age-related decline of mitochondrial function culminat-ing in increased apoptosis. Proc. Natl. Acad. Sci. USA 98(5), 2278–2283.
Cai, J., et al. (2000) Separation of cytochrome c-dependent caspase activation from thiol-disulfide redox change in cells lacking mitochondrial DNA. Free Radical Biol. Med. 29(3-4), 334–342.
Nakahara, H., et al. (1998) Mitochondrial dysfunction in the senescence acceler-ated mouse (SAM). Free Radical Biol. Med. 24(1), 85–92.
Williams, M. D., et al. (1998) Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice. J. Biol. Chem. 273(43), 28,510–28,515.
Melov, S., et al. (2000) Extension of life-span with superoxide dismutase/catalase mimetics. Science 289(5484), 1567–1569.
Wei, M. C., Zong, W. X., Cheng, E. H., Lindsten, T., et al. (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292(5517), 727–730.
Yoshida, H., et al. (1998) Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 94(6), 739–750.
Cecconi, F., et al. (1998) Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell 94(6), 727–737.
Kuida, K., et al. (1998) Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 94(3), 325–337.
Hakem, R., et al. (1998) Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94(3), 339–352.
Kuida, K., et al. (1996) Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384(6607), 368–372.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Humana Press Inc.
About this protocol
Cite this protocol
Wallace, D.C. (2002). Animal Models for Mitochondrial Disease. In: Copeland, W.C. (eds) Mitochondrial DNA. Methods in Molecular Biology™, vol 197. Humana Press. https://doi.org/10.1385/1-59259-284-8:003
Download citation
DOI: https://doi.org/10.1385/1-59259-284-8:003
Publisher Name: Humana Press
Print ISBN: 978-0-89603-972-8
Online ISBN: 978-1-59259-284-5
eBook Packages: Springer Protocols